These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 11856863)
1. Microvascular complications in cystic fibrosis-related diabetes mellitus: a case report. Scott AI; Clarke BE; Healy H; D Emden M; Bell SC JOP; 2000 Nov; 1(4):208-10. PubMed ID: 11856863 [TBL] [Abstract][Full Text] [Related]
3. Microvascular complications in cystic fibrosis-related diabetes. Schwarzenberg SJ; Thomas W; Olsen TW; Grover T; Walk D; Milla C; Moran A Diabetes Care; 2007 May; 30(5):1056-61. PubMed ID: 17322485 [TBL] [Abstract][Full Text] [Related]
4. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use. Al-Aloul M; Miller H; Alapati S; Stockton PA; Ledson MJ; Walshaw MJ Pediatr Pulmonol; 2005 Jan; 39(1):15-20. PubMed ID: 15521084 [TBL] [Abstract][Full Text] [Related]
5. Novel approach to the eradication of Pseudomonas aeruginosa in an infant with CF after outpatient treatment failure. Hayes D; Kanga JF; Anstead MI; Kuhn RJ Pediatr Pulmonol; 2008 May; 43(5):511-3. PubMed ID: 18383117 [TBL] [Abstract][Full Text] [Related]
11. Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy. Hoffmann IM; Rubin BK; Iskandar SS; Schechter MS; Nagaraj SK; Bitzan MM Pediatr Pulmonol; 2002 Nov; 34(5):375-7. PubMed ID: 12357482 [TBL] [Abstract][Full Text] [Related]
12. Diabetes mellitus and bone disease in cystic fibrosis. Curran DR; McArdle JR; Talwalkar JS Semin Respir Crit Care Med; 2009 Oct; 30(5):514-30. PubMed ID: 19760539 [TBL] [Abstract][Full Text] [Related]
13. Aminoglycoside ototoxicity susceptibility in cystic fibrosis. Mulrennan SA; Helm J; Thomas RB; Dodd M; Jones A; Webb K Thorax; 2009 Mar; 64(3):271-2. PubMed ID: 19252031 [No Abstract] [Full Text] [Related]
14. Isolation, motivation and balance: living with type 1 or cystic fibrosis-related diabetes. Tierney S; Deaton C; Webb K; Jones A; Dodd M; McKenna D; Rowe R J Clin Nurs; 2008 Apr; 17(7B):235-43. PubMed ID: 18578799 [TBL] [Abstract][Full Text] [Related]
15. Risk factors for increased need for intravenous antibiotics for pulmonary exacerbations in adult patients with cystic fibrosis. Jarad NA; Giles K Chron Respir Dis; 2008; 5(1):29-33. PubMed ID: 18303099 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of β-lactams as single agents for treating severe pulmonary exacerbations during pregnancy in cystic fibrosis. Prickett M; Jain M Am J Respir Crit Care Med; 2012 Dec; 186(12):1310-1. PubMed ID: 23250504 [No Abstract] [Full Text] [Related]
17. Breast-feeding in a woman with cystic fibrosis undergoing antibiotic intravenous treatment. Festini F; Ciuti R; Taccetti G; Repetto T; Campana S; De Martino M J Matern Fetal Neonatal Med; 2006 Jun; 19(6):375-6. PubMed ID: 16801316 [TBL] [Abstract][Full Text] [Related]
18. Antibiotic-related renal failure and cystic fibrosis. Kennedy SE; Henry RL; Rosenberg AR J Paediatr Child Health; 2005 Jul; 41(7):382-3. PubMed ID: 16014148 [TBL] [Abstract][Full Text] [Related]